Clinical Handbook of Psychotropic Drugs 26th edition

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

• Independent, unbiased, up-to-date
• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
• Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
• Potential interactions and side effects summarized in comparison charts
• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• Clearly written patient information sheets can be downloaded as printable PDF files from the Hogrefe website after Registration.

This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition:

• Antidepressants chapter revised extensively and includes new sections on the selective serotonin 5-HT1A agonist gepirone and difficult-to-treat depression
• Antipsychotics chapter includes a new section on the muscarinic agonist/antagonist combination (Xanomeline/trospium chloride), a novel treatment that does not block D2 dopamine receptors. Major revisions to TGA Dosing and Pharmacokinetics
• Drugs for Treatment of Dementia chapter includes donanemab infusion
• Drugs for ADHD comparison table expanded
• Drugs of Abuse chapter has been revised extensively and includes a new section on Psychedelics and Dissociative Drugs
• New formulations and trade names include: Abilifi Asimtufii (aripiprazole extended-release 2-monthly injection), Azstarys (serdexmethylphenidate/dexmethylphenidate capsules), CAMCEVI (leuprolide 6-month slow-release SC depot injection), Drizalma Sprinkle (duloxetine capsules), Eldepryl (selegiline tablets and capsules), Esprontia (topiramate oral solution), Exxua (gepirone extended-release tablets), Ketalar (ketamine hydrochloride injection), Kisunla (donanemab infusion), Lybalvi (olanzapine/samidorphan tablets), Onyda (clonidine extended-release suspension), Relexii (methylphenidate extended-release tablets), Secuado (asenapine transdermal patch), Zurzuvae (zuranolone capsules)